What You Should Know:
- Veracyte, Inc. (Nasdaq: VCYT), a cancer diagnostics company acquires C2i Genomics, Inc., a pioneer in minimal residual disease (MRD) detection.
- Under the terms of the agreement, Veracyte will pay $70 million in Veracyte shares at closing, and up to an additional $25 million based on the achievement of future performance milestones over the next two years, payable in Veracyte shares or cash at Veracyte’s election.
- This strategic move positions Veracyte to
Read More
Cityblock Expands Access for High-Risk Medicaid Members in Ohio
What You Should Know:
- Buckeye Health Plan and Cityblock are teaming up to provide integrated, community-based care to approximately 10,000 underserved Medicaid recipients in the Cleveland-Akron-Canton area.
- The strategic partnership promises to redefine healthcare delivery for vulnerable communities, prioritizing whole-person health and tackling barriers to access in Ohio.
Building Bridges, Improving Outcomes
Buckeye is a leading Ohio Medicaid managed care plan serving over
Read More
Amazon Unveils Health Condition Programs Making Chronic Condition Management Easier
What You Should Know:
- Amazon launches its new Health Condition Programs to simplify access to digital health benefits offered by insurance plans and employers.
- By partnering with companies like Omada Health, Amazon brings awareness and enrollment options directly to patients where they're already looking for health information. This collaboration targets conditions like diabetes prevention, diabetes management, and hypertension, impacting millions of Americans.
How Amazon’s Health
Read More
Amgen Builds Generative AI Models for Human Data Analysis and Drug Discovery
What You Should Know:
- Amgen, a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja.
- The new initiative will harness the power of an NVIDIA DGX SuperPOD, christened after the Norse goddess of prediction, to accelerate drug discovery and development through AI-powered insights from one of the world's largest human datasets.
Advance Drug Discovery Using NVIDIA DGX SuperPOD-Powered Insight
Human Diversity Atlas: Freyja will map the landscape
Read More
Abbott & Tandem Integrate to Bring Automated Insulin Delivery to US
What You Should Know:
- Tandem Diabetes Care and Abbott have joined forces to bring the first automated insulin delivery (AID) system in the US compatible with Abbott's latest FreeStyle Libre 2 Plus sensor.
- The integration brings the benefits of advanced closed-loop technology to millions of Americans living with diabetes, helping them achieve better blood sugar control and manage their condition with greater ease.
Seamless Integration for Precise Control:
The t:slim X2 insulin
Read More
Socially Determined and Uber Health Partner to Bridge Healthcare and Social Needs
What You Should Know:
- Socially Determined, the leading social risk analytics company, and Uber Health, the healthcare platform for seamless benefit coordination, have announced a partnership to empower individuals and families facing common healthcare challenges.
- The strategic joint effort focuses on connecting vulnerable Medicaid, Medicare Advantage, and commercially insured beneficiaries with critical supplemental benefits like transportation, food delivery, and medication
Read More
Harris Acquires MEDHOST to Expand Healthcare Footprint
What You Should Know:
- Harris, a global vertical market software provider, acquires MEDHOST, Inc., a prominent player in electronic health records (EHR) and healthcare IT solutions to bolster its healthcare offerings.
- The strategic acquisition also encompasses MEDTEAM Solutions, a dedicated service provider specializing in application, revenue cycle, IT, and security management.
Strengthening Community Healthcare
MEDHOST brings to the table a comprehensive suite of clinical and
Read More
QuantHealth Scores $17M to Supercharge AI-Driven Clinical Trials
What You Should Know:
- In a decisive move towards faster and more efficient drug development, QuantHealth, a leading AI-powered clinical trial design company, has secured a strategic investment of $17M.
- The new capital, fueled by Accenture Ventures alongside a prominent CRO and additional investors, bolsters QuantHealth's total Series A funding and propels its mission to revolutionize clinical trials through AI simulations.
Saving Millions with 86% Predictive
Read More
GE HealthCare Acquires MIM Software to Enhance Precision Care
What You Should Know:
- In a move poised to reshape the landscape of precision care, GE HealthCare (Nasdaq: GEHC) has announced the acquisition of MIM Software, a provider of medical imaging analysis and AI solutions.
- This strategic acquisition strengthens GE HealthCare's commitment to developing smart, interconnected devices and digital solutions that empower clinicians to deliver more precise, personalized care across various specialties.
Fueling Innovation in Precision
Read More
Deloitte Unveils Atlas AI: Accelerating Drug Discovery with Generative AI and NVIDIA Power
What You Should Know:
- Deloitte, a global leader in professional services, has unveiled Atlas AI, a groundbreaking addition to its Quartz AI™ suite, marking a significant leap forward in life sciences and healthcare (LSHC).
- Built on the NVIDIA AI and NVIDIA Omniverse™ platforms, Atlas AI empowers scientists with novel tools to expedite drug discovery and bring life-saving treatments to market faster.
Harnessing the Power of Generative AI
Atlas AI boasts a unique arsenal of AI
Read More
